Asger Wretlind

8PUBLICATIONS
54CO-AUTHORS
Central nervous systemPredictive and prognostic markersMedical biochemistry - carbohydratesMetabolic medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 18, 2026
Polyol pathway dysregulation in CSF links glucose metabolism to tau pathology independently of amyloid and genetic predisposition.

|Jul 21, 2023
Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes.

Asger Wretlind, Viktor R Curovic, Tommi Suvitaival

|May 03, 2023
Identification of biomarkers for glycaemic deterioration in type 2 diabetes.

Roderick C Slieker, Louise A Donnelly, Elina Akalestou

|Apr 26, 2022
Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion.

Eleni Georgiadou, Charanya Muralidharan, Michelle Martinez

|Sep 21, 2021
Author Correction: Intravital imaging of islet Ca2+ dynamics reveals enhanced β cell connectivity after bariatric surgery in mice.

Elina Akalestou, Kinga Suba, Livia Lopez-Noriega

|Sep 14, 2021
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial.

Emilie H Zobel, Asger Wretlind, Rasmus S Ripa

Pageof 2

Frequent Collaborators

5 joint publications

Guy A Rutter

3 joint publications

Eleni Georgiadou

2 joint publications

Roderick C Slieker

2 joint publications

Hugo Fitipaldi